Rejoni
Develops a hydrogel system to treat uterine health conditions and prevent scarring
$25MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops a hydrogel system to treat uterine health conditions and prevent scarring
Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
Pitching FemHealth Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room